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Neuroinflammation is characterized by activation of microglial cells, followed by production
of nitric oxide (NO), which may have different outcomes on neurogenesis, favoring or
inhibiting this process. In the present study, we investigated how the inflammatory
mediator NO can affect proliferation of neural stem cells (NSCs), and explored possible
mechanisms underlying this effect. We investigated which mechanisms are involved in
the regulation of NSC proliferation following treatment with an inflammatory stimulus
(lipopolysaccharide plus IFN-γ), using a culture system of subventricular zone (SVZ)-derived
NSCs mixed with microglia cells obtained from wild-type mice (iNOS+/+) or from iNOS
knockout mice (iNOS−/−). We found an impairment of NSC cell proliferation in iNOS+/+
mixed cultures, which was not observed in iNOS−/− mixed cultures. Furthermore, the
increased release of NO by activated iNOS+/+ microglial cells decreased the activation of
the ERK/MAPK signaling pathway, which was concomitant with an enhanced nitration
of the EGF receptor. Preventing nitrogen reactive species formation with MnTBAP, a
scavenger of peroxynitrite (ONOO−), or using the ONOO− degradation catalyst FeTMPyP,
cell proliferation and ERK signalingwere restored to basal levels in iNOS+/+ mixed cultures.
Moreover, exposure to the NO donor NOC-18 (100μM), for 48 h, inhibited SVZ-derived NSC
proliferation. Regarding the antiproliferative effect of NO, we found that NOC-18 caused
the impairment of signaling through the ERK/MAPK pathway, which may be related to
increased nitration of the EGF receptor in NSC. Using MnTBAP nitration was prevented,
maintaining ERK signaling, rescuingNSCproliferation.We show that NO from inflammatory
origin leads to a decreased function of the EGF receptor, which compromised proliferation
of NSC. We also demonstrated that NO-mediated nitration of the EGF receptor caused a
decrease in its phosphorylation, thus preventing regular proliferation signaling through the
ERK/MAPK pathway.
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INTRODUCTION
Brain inflammation was shown to be detrimental to neu-
rogenesis (Ekdahl et al., 2003; Monje et al., 2003). However,
the inflammatory factors underlying the negative effects of
Abbreviations: bFGF, basic fibroblast growth factor; BSA, bovine serum albu-
min; BrdU, 5-bromo-2′-deoxyuridine; NOC-18, DETA-NONOate; DIV, days
in vitro; EdU, 5-ethynyl-2′-deoxyuridine; EGF, epidermal growth factor; EGFR,
epidermal growth factor receptor; ERK, extracellular signal-regulated kinase;
FeTMPyP, 5,10,15,20-tetrakis(N-methyl-4′-pyridyl)porphinate iron (III) chlo-
ride; HBSS, Hank’s balanced salt solution; iNOS, inducible nitric oxide syn-
thase; IFN-γ, interferon-gamma; LPS, lipopolysaccharide; MAPK, mitogen-
activated protein kinases; M-CSF, macrophage colony stimulating factor;
MnTBAP, Mn(III)tetrakis(4-benzoic acid)porphyrin chloride; NOC-18, (Z)-1-[N-
(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate; NO, nitric
oxide; 3-NT, 3-nitrotyrosine; NSCs, neural stem cells; ONOO−, peroxynitrite; PBS,
phosphate-buffered saline; SVZ, subventricular zone.
inflammation on the formation of new brain cells are not fully
identified. NSCs and precursors proliferate throughout life in two
regions of the adult central nervous system, namely in the SVZ of
the lateral ventricles and the subgranular zone (SGZ)of the dentate
gyrus of the hippocampus, as reviewed by Ming and Song (2011).
Newborn cells can differentiate into various cell types, including
neurons and glia (Eriksson et al., 1998; Gage, 2000; Alvarez-Buylla
et al., 2002). The proliferation of NSC in the SVZ or SGZ, an
initial step in the neurogenic process, increases following sev-
eral insults to the brain, such as ischemic stroke (Arvidsson et al.,
2002) or seizures (Parent et al., 1997), which might be part of the
mechanisms supporting self-repair (Lowenstein and Parent, 1999;
Curtis et al., 2007). Thus, the identification of potential thera-
peutic targets for the modulation of endogenous or exogenously
induced neurogenesis is of great interest (Taupin, 2005;
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Madhusoodanan and Murad, 2007). Microglial cells are highly
dynamic sensors that continually scan the surrounding tis-
sue (Davalos et al., 2005; Nimmerjahn et al., 2005). Upon an
injury, or change in the environment, microglia promptly
respond with morphological and biochemical changes, produc-
ing and releasing a plethora of signaling molecules such as NO
(Kettenmann et al., 2011).
Nitric oxide is a highly reactive diffusible signaling molecule,
with pleiotropic effects in biological systems, having a half-life
of few seconds. Upon neurotoxic, traumatic, and inflammatory
damage in the mammalian brain, NO is formed in high amounts,
following the expression of the iNOS (Chao et al., 1992; Galea
et al., 1992; Nathan and Xie, 1994; Murphy, 2000; Calabrese et al.,
2009). The increasing list of functions for NO from inflamma-
tory origin includes bactericidal action, control of cerebral blood
flow, regulation of endocytosis and vesicle recycling, and modula-
tion of neurotransmission (Lane and Gross, 1999; Ignarro, 2000;
Calabrese et al., 2007). One of the main mechanisms by which
NO exerts its cellular functions is at the level of post-translational
protein modification (Guix et al., 2005). Protein nitration results
from the reaction of ONOO−, originated by reaction of NO
with superoxide, with amino acidic residues such as tryptophan
and tyrosine. Moreover, S-nitrosylation occurs when NO reacts
with thiol groups of several amino acidic residues, particularly
with cysteine. Both nitration and S-nitrosylation typically lead
to alterations in protein function, with different outcomes in
the cellular metabolism (Hanafy et al., 2001). In fact, reactive
nitrogen and oxygen species are important factors in the inflam-
matory responses mediated by microglial cells (Rock et al., 2004).
On the other hand, inflammation has different effects on neu-
rogenesis and, particularly when inflammation occurs following
tissue damage, it inhibits the neurogenic process (Ekdahl et al.,
2003, 2009; Kempermann and Neumann, 2003; Monje et al.,
2003).
Neural progenitor cells in the SVZ are anatomically in close
proximity to NO-producing cells (Matarredona et al., 2005). Sev-
eral studies have suggested that NO inhibits proliferation of NSCs
under physiological conditions (Packer et al., 2003; Moreno-Lopez
et al., 2004; Matarredona et al., 2005). In isolated NSC from the
SVZ, supraphysiological concentrations of NO also inhibit NSC
proliferation and promote differentiation of precursors into astro-
cytes (Covacu et al., 2006; Torroglosa et al., 2007; Bergsland et al.,
2014). Torroglosa et al. (2007) have suggested that NO modulates
the tyrosine kinase activity of EGF receptor (EGFR), although
the precise underlying molecular mechanisms remain unclear. To
date, the signaling pathways involved in the proliferative effect of
NO following brain injury and the molecular mechanisms of its
antiproliferative effect were not identified.
In the present study, we investigated how NO produced by
microglia in inflammatory conditions can affect proliferation of
NSCs, and assessed the mechanisms underlying the effects of NO
onproliferation. To better understandwhether andhowNOmedi-
ates the detrimental effects of inflammation on NSC proliferation,
we used a mixed culture system of SVZ-derived stem cells cul-
tured with microglia isolated from wild-type mice (iNOS+/+)
or knockout mice (iNOS−/−). We show, for the first time, that
inflammatory NO produced by microglia has an antiproliferative
effect through the decreased activation of the ERK/MAPK signal-
ing pathway, an event for which the nitration of the EGFR plays
an essential role, impairing NSC proliferation.
MATERIALS AND METHODS
MATERIALS
Dulbecco’s Modified Eagle’s Medium:F-12 nutrient mixture
(D-MEM/F-12, with GlutaMAXTM-I), B27 supplement, trypsin-
EDTA solution (0.05% trypsin, 1 mM EDTA in HBSS), gen-
tamicin, antibiotics (10,000 units/ml of penicillin, 10 mg/ml
streptomycin), and trypsin (1:250)were purchased fromLife Tech-
nologies (Carlsbad, CA, USA). Deoxyribonuclease 1 (DNase-1),
BrdU, phenylmethylsufonyl fluoride, dithiothreitol, orthovana-
date, chymostatin, leupeptin, antiparin, pepstatin A, trypan
blue, LPS, and alkaline phosphatase-linked anti-rabbit secondary
antibody were purchased from Sigma Chemical (St Louis, MO,
USA). BCATM Protein Assay kit was obtained from Pierce (Rock-
ford, IL, USA). EGF, bFGF, Click-iT® EdU Alexa Fluor® 647
HCS Assay, Hoechst 33342, anti-mouse IgG conjugated with
Alexa Fluor 594 or 488, and anti-rabbit IgG conjugated with
Alexa Fluor 633, 594, or 488 secondary antibodies were pur-
chased from Life Technologies (Carlsbad, CA, USA). Cellulose
acetate (0.45 μm) was obtained from Corning Inc. (Lowell,
MA, USA). M-CSF and IFN-γ were purchased from Pepro-
tech (London, UK) and NOC-18 from Alexis Biochemicals (San
Diego, CA, USA). BSA and MnTBAP were obtained from Cal-
biochem (San Diego, CA, USA). The antibody against 3-NT
conjugated with agarose beads and FeTMPyP were purchased
from Cayman Chemical (Tallinn, Estonia). Rabbit anti-GFAP
and DAKO fluorescent mounting medium were obtained from
DakoCytomation (Glostrup, Denmark). Rat anti-mouse BrdU
was obtained from Oxford Biotechnology and rat anti-mouse
CD11b from Serotec (Oxford, UK). Mouse anti-nestin, rabbit
anti-iNOS and mouse anti-GAPDH were purchased from BD
Transduction (San Jose, CA, USA). Mouse anti-3-nitrotyrosine
was purchased from Upstate Biotechnology (Charlottesville, VA,
USA), while rabbit anti-EGFR, rabbit anti-phospho-Tyr1173-
EGFR, rabbit anti-phospho-ERK1/2 and mouse anti-ERK1/2 were
purchased from Cell Signaling (Danvers, MA, USA). Rabbit anti-
nestin was obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) and mouse anti-Sox-2 from R&D Systems (Min-
neapolis, MN, USA). Griess Reagent System was obtained from
Promega (Madison, WI, USA). Polyvinylidene difluoride (PVDF)
membranes, enhanced chemifluorescence (ECF) reagent and alka-
line phosphatase-linked anti-rabbit and anti-mouse secondary
antibodies were obtained from Amersham Pharmacia Biotech
(Buckinghamshire, UK). Other reagents used in immunoblot-
ting experiments were purchased from BioRad (Hercules, CA,
USA).
ANIMALS
C57BL/6J (iNOS+/+) mice or B6.129P2-Nos2tm1Lau/J (iNOS−/−)
were obtained from Charles River (Barcelona, Spain) or The Jack-
sonLaboratory (BarHarbor,ME,USA), respectively, and keptwith
food andwater ad libitum in a 12hdark:light cycle. All experiments
were performed in accordance with NIH and European guide-
lines (86/609/EEC) for the care and use of laboratory animals. In
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addition, all the people working with animals have received appro-
priate education (FELASA course) as required by the Portuguese
authorities. Furthermore, the animals were housed in our licensed
animal facility (International Animal Welfare Assurance number
520.000.000.2006). This study is part of a grant approved and
financed by the Foundation for Science and Technology, (FCT,
Portugal), that approved the animal experimentation described
(reference PTDC/SAU-NEU/102612/2008).
PRIMARY MICROGLIAL CELL CULTURES
Primary glial cultures were prepared from the brains of 0 to 3-day-
old C57BL/6J (iNOS+/+) or B6.129P2-Nos2tm1Lau/J (iNOS−/−)
mice according to the method of Giulian and Baker (1986).
Briefly, the brains were removed from the skull, following decap-
itation, and placed in dissection medium composed of Ca2+-
and Mg2+-free HBSS (137 mM NaCl, 5.36 mM KCl, 0.44 mM
KH2PO4, 0.34 mM Na2PO4 · 2H2O, 4.16 mM NaHCO3, 5 mM
glucose, 1 mM sodium pyruvate, 10 mM HEPES, pH 7.4), sup-
plemented with 0.25% gentamicin. The enveloping meninges and
the cerebellum were discarded and the cortex tissue was mechan-
ically dissociated and digested with trypsin (0.1%) and DNase 1
(0.001%) in Ca2+- and Mg2+- free HBSS for 20 min, at 37◦C.
Cells were seeded in 75 cm2 flasks coated with poly-L-lysine, at
a density of 0.2 × 106 cells/cm2 and cultured in D-MEM/F-12
with GlutaMAXTM-I supplemented with 10% FBS, 0.25% gen-
tamicin and 0.25 ng/ml M-CSF, at 37◦C and 95% air-5% CO2 in
a humidified incubator. Culture medium was changed every 3–
4 days and confluency was achieved after 10–14 DIV. Microglia
were detached from the mixed glial cultures 3–10 days after reach-
ing confluency, by shaking at 200 rpm for 2 h, and collected from
the supernatant by centrifuging at 1500 rpm, for 5 min. Cells
were then seeded for 3 days at a density of 0.035 × 106 cells/cm2
onto 16-mm diameter glass coverslips, for immunocytochemistry
assays, or on 12-well plates, for preparation of lysates, both coated
with poly-L-lysine, in serum-free medium, without M-CSF. Next,
cultures were treated with an acute inflammatory stimulus (except
the controls): 100 ng/ml LPS plus 0.5 ng/ml IFN-γ, for 24 h (Saura
et al., 2003).
SUBVENTRICULAR ZONE CELL CULTURES
Neural stem cell cultures were obtained from the SVZ of post-
natal day 0–3 wild-type or transgenic C57BL/6J mice expressing
enhanced green fluorescent protein (GFP) under the control of the
actin promoter, as previously described by Carreira et al. (2010).
The SVZ-derived NSCs were allowed to develop as primary neu-
rospheres in a 95% air-5% CO2 humidified atmosphere at 37◦C,
during 7 days. Next, neurospheres were collected, dissociated
and plated for 5 days on 16-mm diameter glass coverslips, for
immunocytochemistry assays, or on 12-well plates, coated with
poly-L-lysine, in the same medium as above, without growth
factors, for preparation of lysates.
MIXED CELL CULTURES
Green fluorescent protein-positive SVZ neurospheres were col-
lected, dissociated andplated togetherwith iNOS+/+ or iNOS−/−
microglial cell cultures (from now on denominated as iNOS+/+
or iNOS−/− mixed cultures, respectively) on 16-mm diameter
glass coverslips, for immunocytochemistry assays, or on 12-well
plates, for preparation of lysates, both coated with poly-L-lysine,
and kept in fresh D-MEM/F-12 with GlutaMAXTM-I medium,
supplemented with 1% B27, 0.25% gentamicin, 10 ng/ml EGF
and 10 ng/ml bFGF, at 37◦C and 95% air-5% CO2 in a humid-
ified incubator, for 3 days. GFP-positive SVZ neurospheres were
also dissociated and seeded alone, for 3 days, on 16-mm diame-
ter coverslips or on 12-well plates, coated with poly-L-lysine, and
cultured in the same medium as above, for control experiments.
Cultures were treated with 100 ng/ml LPS plus 0.5 ng/ml IFN-γ,
for 24 h. Control cultures were left untreated. The cell-permeable
superoxide dismutase mimetic and ONOO− scavenger MnTBAP
(100 μM; Szabo et al., 1996) or the ONOO− decomposition cata-
lyst FeTMPyP (50 μM; Misko et al., 1998), when used, were added
30 min before LPS plus IFN-γ and kept throughout the incubation
period.
EXPERIMENTAL TREATMENTS IN SVZ-DERIVED NEURAL STEM CELL
CULTURES
Subventricular zone-derived NSC were exposed to the NO donor
NOC-18 (100 μM) for 48 h. MnTBAP (100 μM) and FeTMPyP
(50 μM),were added 30 min before NOC-18 and kept throughout
the incubation period.
DETECTION OF BrdU INCORPORATION IN SVZ-DERIVED NEURAL STEM
CELL CULTURES
To analyze proliferation of SVZ-derived NSCs, 10 μM BrdU was
added to the cultures 16 h prior to fixation (Alvaro et al., 2008;
Carreira et al., 2010). Nuclei that incorporated BrdU in this time-
window were detected by immunofluorescence, as detailed next.
Following 20 min fixation with 4% paraformaldehyde/4% sucrose
in PBS (0.1 M), the cells were permeabilized with 1% Triton X-100
for 5 min, and DNA was denaturated by treatment with 1 M HCl
for 30 min, at 37◦C. Non-specific binding was blocked with 3%
BSA in 0.2% Tween-20 in PBS (PBS-T) for 1 h, and then BrdU-
positive cells were labeled with a rat anti-BrdU antibody (1:50) for
90 min, at room temperature. The cells were then incubated with a
secondary antibody goat anti-rat IgG conjugated with Alexa Fluor
594 (1:200), for 1 h, at room temperature. Nuclei were stained
withHoechst 33342 (1μg/ml) for 5min. Coverslipsweremounted
on glass slides using DAKO fluorescence mounting medium. The
images were acquired in a laser-scanning microscope LSM 510
META (Zeiss, Jena, Germany) or in a fluorescence microscope
(Axioskop 2 Plus, Zeiss, Jena, Germany). The number of BrdU-
positive nuclei was counted in 8–10 randomly selected fields for
each coverslip (in a total of ∼900–1,200 cells per coverslip), and
the data were expressed as percentage of the total number of live
cells. A minimum of three independent experiments, from NSC
cultures prepared from different animals, was analyzed for each
condition.
DETECTION OF EdU INCORPORATION
Neural stem cell proliferation was also assessed by incorpora-
tion of the thymidine analog EdU, which is incorporated into
DNA of dividing cells during S phase (Buck et al., 2008; Cappella
et al., 2008; Chehrehasa et al., 2009). EdU (10 μM) was added
to the cultures 4 h prior to fixation. Nuclei that incorporated
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EdU in this time-window were detected by immunofluorescence,
as follows. Following 20 min fixation with 4% paraformalde-
hyde/4% sucrose in PBS (0.1 M), the cells were washed with 3%
BSA/PBS and then permeabilized with 0.5% Triton X-100/PBS
for 15 min, at room temperature. The cells were then incubated
with the Click-iT reaction cocktail [1x at 87.5% (v/v) Click-iT
Reaction Buffer, 2% (v/v) CuSO4, 0.05% (v/v) fluorescent azide
(Alexa Fluor 647), and 1x at 10% (v/v) Reaction Buffer Addi-
tive], protected from light. Cells were then washed twice in 3%
BSA/PBS and an immunocytochemistrywas performed as detailed
next.
The number of EdU-positive nuclei was counted in 8–10 ran-
domly selected fields for each coverslip (in a total of ∼900–1,200
cells per coverslip), and the data were expressed as percentage of
the total number of live cells. A minimum of three independent
experiments was analyzed for each condition.
IMMUNOCYTOCHEMISTRY
Following fixation andpermeabilization, non-specific bindingwas
blocked with 3% BSA. Cells were incubated with the primary anti-
bodies for 90 min, at room temperature. After rinsing with PBS,
the cells were incubatedwith the appropriate secondary antibodies
for 1 h (1:200, anti-mouse, anti-rabbit or anti-rat IgGs conjugated
with Alexa Fluor 488, 594, or 633), at room temperature. All anti-
bodies were prepared in blocking solution. Nuclei were labeled
with Hoechst 33342 (1 μg/ml) for 5 min, after incubation with the
secondary antibodies. Coverslips weremounted on glass slides, the
cells were visualized using a fluorescence microscope (Axioskop 2
Plus, Zeiss, Jena, Germany) and the images were acquired with
the Axiovision software (release 4.7) or in a laser scanning fluo-
rescence microscope LSM 510 META (Zeiss, Jena, Germany). The
primary antibodies and the concentrations usedwere: mouse anti-
Sox-2, 1:100; rabbit anti-nestin, 1:100; rabbit anti-GFAP, 1:400;
mouse anti-nestin, 1:500; rat anti-mouse-CD11b, 1:200; rabbit
anti-iNOS, 1:200.
EVALUATION OF NITRIC OXIDE PRODUCTION
Nitric oxide production was indirectly assessed by measuring the
concentration of nitrites in the culture medium (Green et al.,
1982), in primary microglia cultures, SVZ-derived NSC cultures
or mixed cell cultures. A commercial kit from Promega was used,
and the standard protocol provided by the supplier was followed.
The concentration of nitrite for each sample was calculated from
a standard curve using a sodium nitrite solution and data were
expressed in μM.
WESTERN BLOT ANALYSIS
Cells were lysed in 50 mM Tris-HCl, 10 mM EGTA, 1% Tri-
ton X-100 and 2 mM MgCl2, supplemented with 100 μM
phenylmethylsufonyl fluoride, 1 mM dithiothreitol, 1 μg/ml chy-
mostatin, 1 μg/ml leupeptin, 1 μg/ml antiparin, 5 μg/ml pepstatin
A, 1 mM sodium orthovanadate, 50 mM NaF, pH 7.4, at 4◦C.
Protein concentration was determined by the bicinchoninic acid
(BCA) method, and the samples were used for Western blot anal-
ysis, after adding 6x concentrated sample buffer [0.5 M Tris, 30%
glycerol, 10% sodium dodecyl sulfate (SDS), 0.6 M dithiothre-
itol, 0.012% bromophenol blue] and heating, for 5 min, at 95◦C.
Equal amounts of protein were separated by electrophoresis on
SDS-polyacrylamide gels, and transferred electrophoretically to
PVDF membranes. These were then blocked for 1 h at room
temperature, in Tris-buffered saline (137 mM NaCl, 20 mM Tris-
HCl, pH 7.6) containing 0.1% Tween-20 (TBS-T) and 3% BSA.
Incubations with primary antibodies (anti-iNOS or anti-GAPDH,
1:500; rabbit anti-phospho-Tyr1173-EGFR, rabbit anti-EGFR,
rabbit anti-phospho-ERK1/2 and mouse anti-ERK1/2, 1:1,000)
in TBS-T with 1% BSA were performed overnight, at 4◦C. Next,
the membranes were incubated for 1 h at room temperature with
alkaline phosphatase-linked secondary antibodies (anti-rabbit or
anti-mouse IgG, 1:20,000) in TBS-T with 1% BSA. After extensive
washing in TBS-T with 0.5% BSA, immunoreactive bands were
visualized in the VersaDoc 3000 imaging system (BioRad, Her-
cules, CA,USA), following incubation of the membrane with ECF
reagent for 5 min.
IMMUNOPRECIPITATION
Following the various experimental treatments, as detailed in
figure legends, the cultures were lysed in 20mMTris-HCl, 100mM
NaCl, 2 mM EDTA, 2 mM EGTA, supplemented with 100 μM
PMSF, 1 mM dithiothreitol, 1 μg/ml chymostatin, 1 μg/ml leu-
peptin, 1 μg/ml antiparin, 5 μg/ml pepstatin A, 1 mM sodium
orthovanadate, 50 mM NaF, pH 7.0, at 4◦C. Protein concentra-
tion was determined by the BCA method, and the samples were
used for immunoprecipitation of nitrated proteins, using an anti-
body against 3-NT conjugated with agarose beads. Briefly, equal
amounts of sample (250 μg of protein) were incubated with the
antibody overnight at 4◦C, and then with the beads for 2 h at room
temperature. Following rinsing, the supernatant was discarded
and the beads were suspended in 2x concentrated sample buffer,
boiled for 5 min, and centrifuged using Spin-X centrifuge tube
filters (0.45 μm cellulose acetate), to separate the beads from the
immunoprecipitates. Equal volumes of immunoprecipitate were
loaded onto SDS-PAGE gels, and Western blotted as described
above against the EGF receptor.
STATISTICAL ANALYSIS
Data are expressed as mean ± SEM. Statistical significance was
determined by using two-tailed t-tests, one-factor or two-factor
analysis of variance (ANOVA) as appropriate, followed by post
hoc Bonferroni’s or Dunnet’s tests, as indicated in the figure leg-
ends and in the text. Differences were considered significant when
p < 0.05.
RESULTS
INFLAMMATORY STIMULATION INCREASES iNOS EXPRESSION AND
NO FORMATION
Neural stem cells were isolated from the SVZ and cultured as float-
ing aggregates, also referred as neurospheres. Neurospheres were
then dissociated and plated on poly-L-lysine-coated coverslips for
3–5 days, and characterized at this stage. Staining against the tran-
scription factor Sox-2, and against nestin, a neural precursor cell
marker, was performed. The percentage of double-labeled cells
was approximately 70%, which suggests that the majority of cells
remained undifferentiated after plating as shown previously by
our group (Carreira et al., 2010).
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Microglial cells were seeded on poly-L-lysine-coated cover-
slips for 3 days and challenged with an inflammatory stimulus,
LPS (100 ng/ml) plus IFN-γ (0.5 ng/ml), for 24 h. Cultures
were then characterized by evaluatingmicroglial cellsmorphology,
iNOS expression and NO production. In iNOS+/+ microglial cell
cultures, exposure to LPS plus IFN-γ increased iNOS immunore-
activity, but not in iNOS−/− microglial cell cultures (Figure 1A),
as expected. Concomitantly, following treatment with LPS plus
IFN-γ, both iNOS+/+ and iNOS−/− microglial cells exhibited
an activated morphology with ovaloid cytoplasm, marked cellu-
lar hypertrophy and retraction of processes. In order to estimate
the amount of NO produced by activated microglia in cul-
ture, we assessed NO production by measuring nitrite levels in
the culture media following challenging with LPS plus IFN-γ.
Nitrite levels were higher in treated iNOS+/+ microglial cell cul-
tures (1.95 ± 0.3 μM, p < 0.001), than in untreated cultures
(0.32 ± 0.1 μM), corresponding to a 6-fold increase in NO pro-
duction above control levels. In iNOS−/− microglial cell cultures,
treatment with LPS plus IFN-γ did not significantly change NO
levels, as compared to untreated cultures (Figure 1B).
To investigate how inflammation, particularly NO formed due
to microglial activation, could affect the proliferation of SVZ-
derived NSCs, mixed cultures were prepared as described in
Section “Materials and Methods.” We evaluated the expression of
iNOS in iNOS+/+ mixed cultures, following treatment with LPS
plus IFN-γ by immunocytochemistry (Figure 2A) and Western
blot analysis (Figure 2B). In iNOS−/− mixed cultures, iNOS was
not detected, as assessed byWestern blotting, even after the inflam-
matory stimulus (Figure 2B). Furthermore, when measuring
nitrite levels in the culture media, an increase in NO produc-
tion was observed in iNOS+/+ mixed cultures (1.96 ± 0.2 μM,
p < 0.001) following treatment with LPS plus IFN-γ, as compared
to control cultures (0.39 ± 0.1 μM). On the contrary, treatment
with LPS plus IFN-γ for 24 h did not significantly change NO lev-
els in iNOS−/− mixed cultures, as compared to untreated cultures
(Figure 2C).
To determine whether SVZ-derived NSCs contributed to the
increase in iNOS levels observed in mixed cell cultures, we
also evaluated the presence of iNOS in SVZ-derived NSC alone,
and observed a complete absence of immunoreactivity against
iNOS following treatment with LPS plus IFN-γ in these cultures
(Figure 2D). Moreover, treatment with LPS plus IFN-γ for 24 h
did not significantly change NO levels in SVZ-derived NSC cul-
tures, as compared to untreated cultures, as assessed by evaluating
nitrite levels in cultures (Figure 2E).
NO FROM INFLAMMATORY ORIGIN EXERTS AN ANTIPROLIFERATIVE
EFFECT ON SVZ-DERIVED NEURAL STEM CELLS
To determine how NO released from microglial cells affected the
proliferation of SVZ-derived NSCs, we evaluated the incorpora-
tion of EdU in iNOS+/+ or iNOS−/− mixed cultures, following
treatment with LPS plus IFN-γ. In iNOS+/+ mixed cultures,
we observed that EdU incorporation significantly decreased to
7.0 ± 1.09% (p < 0.001), 24 h following exposure to LPS plus IFN-
γ, as compared to control cultures (17.3 ± 0.88%), but the same
stimulus had no effect in EdU incorporation either in iNOS−/−
mixed cultures or in SVZ-derived NSC cultures alone (Figure 3A).
FIGURE 1 | Nitric oxide production and iNOS expression in primary
microglial cell cultures under inflammatory conditions. (A) Exposure to
LPS plus IFN-γ for 24 h triggered the expression of iNOS in iNOS+/+
microglia (CD11b-positive cells), but not in iNOS−/− microglia. Nuclei were
labeled with Hoechst 33342. Scale bar: 20 μm. (B) Production of NO, which
was indirectly measured by quantification of nitrite levels in the culture
media, following treatment with LPS plus IFN-γ for 24 h, in primary
iNOS+/+ or iNOS−/− microglial cell cultures. Two-way ANOVA;
***p < 0.001, significantly different from control.
Moreover, we observed that SVZ-derived NSCs, but not
microglia, incorporated EdU, as illustrated by the presence of
immunoreactivity against EdU in the GFP-positive SVZ cells, but
not in microglial cells, strongly suggesting that these are the divid-
ing cells in mixed cultures (Figure 3B). We also confirmed that
LPS plus IFN-γ for 24 h did not affect cell viability in iNOS+/+
and in iNOS−/− mixed cultures, or in SVZ-derived NSC cultures
(Tables 1 and 2, respectively).
NO FROM INFLAMMATORY ORIGIN DECREASES THE ACTIVATION OF
THE ERK/MAPK SIGNALING PATHWAY
We next investigated the possible mechanism underlying the
observed antiproliferative effect of inflammation in mixed
Frontiers in Cellular Neuroscience www.frontiersin.org October 2014 | Volume 8 | Article 343 | 5
Carreira et al. NO impairment of NSC proliferation
FIGURE 2 | Inflammatory stimulation increases iNOS expression and
NO production in microglia co-cultured with SVZ cells. (A) Presence
of iNOS-positive cells (green) in mixed cultures of iNOS+/+ microglia
(CD11b-positive cells) together with GFP-positive SVZ cells, following
treatment with LPS plus IFN-γ, for 24 h, as compared to controls (upper
panels). Nuclei were labeled with Hoechst 33342 (blue). Scale bar:
20 μm. (B) Detection of iNOS in mixed cultures of SVZ cells with
iNOS+/+ microglia, but not with iNOS−/− microglia, after treatment with
LPS plus IFN-γ for 24 h, as assessed by Western blotting. GAPDH was
used as a loading control. (C) Production of NO, following 24 h treatment
with LPS plus IFN-γ, in mixed cultures. Two-way ANOVA; ***p < 0.001,
significantly different from control. (D) Absence of iNOS immunoreactivity
in SVZ cells cultured alone, upon exposure to LPS plus IFN-γ for 24 h.
GAPDH was used as loading control. (E) NO production after 24 h of
treatment with LPS plus IFN-γ, in SVZ-derived NSC cultures. Two-tailed
t -test; p > 0.05.
cultures. The main regulatory pathway for NSC proliferation is
the signaling cascade of MAPK, particularly the ERK1/2 path-
way. Within this scenario, we evaluated whether inflammation,
particularly NO from inflammatory origin, could affect the acti-
vation and signaling through the ERK/MAPK pathway. We found
that LPS plus IFN-γ decreased the phosphorylation of ERK1/2
in iNOS+/+ mixed cultures (Figure 4, p < 0.001), whereas in
iNOS−/− mixed cultures no changes were observed in the lev-
els of phospho-ERK1/2 following exposure to LPS plus IFN-γ
(Figure 4).
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FIGURE 3 | Nitric oxide from microglial origin impairs the proliferation of
SVZ cells. (A) Incorporation of EdU in mixed or SVZ-derived NSC cultures
following treatment with LPS plus IFN-γ for 24 h. Two-way ANOVA (mixed
culture); ***p < 0.001, significantly different from control. Two-tailed t -test
(SVZ culture); p > 0.05. (B) Representative images of the incorporation of
EdU (white) in GFP-positive SVZ cells (green) cultured together with iNOS+/+
or iNOS−/− microglia (CD11b-positive cells; red), following 24 h exposure to
LPS plus IFN-γ. Scale bar: 20 μm.
To better understand whether the antiproliferative effect of
inflammation in mixed cultures could be due to the production
of highly reactive species, such as ONOO−, we used MnT-
BAP, a superoxide scavenger, thus preventing the production
of ONOO−, and FeTMPyP, which catalyzes the degradation of
ONOO−. We observed that the decreased phosphorylation of
ERK1/2 in iNOS+/+ mixed cultures following treatment with
LPS plus IFN-γ was prevented either by treatment with MnTBAP
or FeTMPyP (Figure 5A, p < 0.001 or p < 0.05, respectively).
Moreover, when MnTBAP or FeTMPyP were present during
the inflammatory stimulus, cell proliferation was rescued to
15.8 ± 0.4% or 14.7 ± 0.8%, respectively, in iNOS+/+ mixed
cultures (Figures 5B,C).
We also investigated the effect of high levels of NO, an event
occurring during inflammation, in the proliferation of SVZ-
derivedNSCcultures. For that, SVZ-derivedNSCswere exposed to
aNOdonor,NOC-18 (100μM), for 48 h.We observed a decreased
phosphorylation of ERK1/2, following exposure to 100 μM NOC-
18 for 48 h, which was prevented by MnTBAP (Figure 6A,
p < 0.05). When assessing NSC proliferation by evaluating BrdU
incorporation following treatment with NOC-18 (100 μM) for
48 h, we observed that NOC-18 significantly decreased BrdU
incorporation to 4.9 ± 0.2% (p < 0.001), as compared to BrdU
incorporation in control cultures (7.7 ± 0.2%). Interestingly,
MnTBAP rescued cell proliferation (7.9 ± 0.66%), when present
during the treatment with NOC-18 for 48 h (Figure 6B). Further-
more, we also confirmed that NOC-18 for 48 h did not affect cell
viability in SVZ-derived NSC cultures (Table 2).
INFLAMMATION INDUCES NITRATION OF THE EGF RECEPTOR AND
DECREASES ITS PHOSPHORYLATION STATUS
We next evaluated whether the inflammatory stimulus induced
the nitration of the EGF receptor in mixed cultures, an event that
could be linked to the inhibition of the downstream signaling
through the ERK/MAPK pathway in mixed cultures treated with
LPS plus IFN-γ. Nitration of tyrosine residues of the EGFR was
evaluated in iNOS+/+ and iNOS−/− mixed cultures. In iNOS+/+
mixed cultures, treatment with LPS plus IFN-γ for 24 h increased
the nitration of the EGFR in immunoprecipitates of nitrated pro-
teins (127.4 ± 5.4%, p < 0.01), as compared to untreated cultures.
Moreover, MnTBAP and FeTMPyP were able to prevent the nitra-
tion of the EGFR in these cultures, after incubation with LPS plus
IFN-γ, reducing EGFR nitration to 68.2 ± 7.2% (p < 0.001) or
84.9 ± 2.4% (p < 0.001) of the control, respectively (Figure 7A,
left pannel). On other hand, this effect was not observed in
iNOS−/− mixed cultures, where treatment with LPS plus IFN-γ
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Table 1 | Cell viability evaluation in iNOS+/+ and iNOS–/– mixed cultures following exposure to LPS plus IFN-γ for 24 h.
Treatment % GFP-live cells % GFP-dead cells
iNOS+/+ Control
LPS plus IFN-γ
LPS plus IFN-γ plus MnTBAP
LPS plus IFN-γ plus FeTMPyP
87.5 ± 1.4
90.3 ± 0.8 (n.s.)
90.7 ± 1.5 (n.s.)
88.8 ± 1.9 (n.s.)
12.5 ± 0.6
9.7 ± 1.1 (n.s.)
9.3 ± 0.8 (n.s.)
11.2 ± 0.9 (n.s.)
iNOS−/− Control
LPS plus IFN-γ
LPS plus IFN-γ plus MnTBAP
LPS plus IFN-γ plus FeTMPyP
92.9 ± 1.5
91.5 ± 1.4 (n.s.)
89.8 ± 1.7 (n.s.)
88.7 ± 1.6 (n.s.)
7.1 ± 1.1
8.5 ± 0.9 (n.s.)
10.2 ± 1.0 (n.s.)
11.3 ± 0.8 (n.s.)
Treatment % CD11b-live cells % CD11b-dead cells
iNOS+/+ Control
LPS plus IFN-γ
LPS plus IFN-γ plus MnTBAP
LPS plus IFN-γ plus FeTMPyP
99.2 ± 0.3
99.5 ± 0.3 (n.s.)
98.7 ± 0.4 (n.s.)
99.0 ± 0.7 (n.s.)
0.8 ± 0.3
0.5 ± 0.1 (n.s.)
1.3 ± 0.5 (n.s.)
1.0 ± 0.6 (n.s.)
iNOS−/− Control
LPS plus IFN-γ
LPS plus IFN-γ plus MnTBAP
LPS plus IFN-γ plus FeTMPyP
98.7 ± 0.4
99.0 ± 0.2 (n.s.)
98.9 ± 0.5 (n.s.)
99.3 ± 0.7 (n.s.)
1.3 ± 0.1
1.0 ± 0.3 (n.s.)
1.1 ± 0.4 (n.s.)
0.7 ± 0.4 (n.s.)
Cell viability was assessed by analysis of nuclear morphology. Cells were considered dead when nuclei were condensed/fragmented and brightly stained with Hoechst
33342. Cells presenting regular nuclear morphology and light nuclear stain with bright nucleoli were considered live cells. n.s. (non-significant) p > 0.05, not different
from the control, one-way ANOVA (Dunnett’s post-test).
did not cause increased nitration of the EGFR (Figure 7A, right
panel).
Next, we analyzed the phosphorylation of the tyrosine residue
1173, which is involved in the activation of the EGFR. LPS plus
IFN-γ caused a decrease in the phosphorylation status of the EGFR
in iNOS+/+ mixed cultures, an event that was prevented either by
MnTBAP or FeTMPyP (Figure 7B, left panel). As expected, in
iNOS−/− mixed cultures no changes were observed in the phos-
phorylation status of the EGFR following exposure to LPS plus
IFN-γ for 24 h (Figure 7B, right panel).
DISCUSSION
In this work, we demonstrated that inflammation has an antipro-
liferative effect on NSC. Furthermore, we show that the inhibitory
effect of inflammation on the proliferation of NSC is mediated by
NO, due to the decreased signaling through the ERK/MAPK path-
way, subsequent to the nitration of the EGF receptor and decrease
of its phosphorylation status.
The effect of inflammation on the proliferation of SVZ-
derived NSCs was studied in this work by establishing mixed
cultures of iNOS+/+ or iNOS−/− microglial cells and SVZ-
derived NSCs. These mixed cultures, when challenged with LPS
plus IFN-γ, are a good system to mimic events occurring in
vivo during an inflammatory response (Cacci et al., 2008) in
the neurogenic niche, particularly NO production, thus allow-
ing us to dissect the involved of NO and underlying mechanism
in the antiproliferative effect of neuroinflammation. To study
more directly the effect of NO in SVZ-derived NSCs, primary
SVZ-derived cell cultures were exposed to high levels of the
NO donor (NOC-18), an experimental condition that mimics
pathophysiological conditions, particularly neuroinflammatory
conditions, when high concentrations of NO can be found
locally in the brain. For this purpose, SVZ-derived NSCs cul-
tures were incubated with 100 μM NOC-18 for 48 h, since it
is a long-acting NO donor with a half-life of ∼22 h (Keefer
et al., 1996). At this concentration (100 μM), NOC-18 released
NO mimicking what might be found in neuroinflammatory
conditions. We did not observe any cytotoxic effect of NO in
Table 2 | Cell viability evaluation in SVZ-derived NSC cultures.
Treatment % live cells % dead cells
24 h Control
LPS plus IFN-γ
92.7 ± 0.9
90.5 ± 0.5 (n.s.)
7.3 ± 0.5
9.5 ± 0.9 (n.s.)
48 h Control
NOC-18
NOC-18 plus MnTBAP
MnTBAP
80.0 ± 2.0
77.5 ± 2.8 (n.s.)
80.2 ± 1.7 (n.s.)
82.6 ± 1.3 (n.s.)
20.0 ± 1.0
22.5 ± 1.2 (n.s.)
19.8 ± 0.9 (n.s.)
17.4 ± 0.8 (n.s.)
Cell viability was assessed by analysis of nuclear morphology. Cells were con-
sidered dead when nuclei were condensed/fragmented and brightly stained with
Hoechst 33342. Cells presenting regular nuclear morphology and light nuclear
stain with bright nucleoli were considered live cells. n.s. (non-significant) p > 0.05,
not different from the control, two-tailed t-test (24 h analysis) or one-way ANOVA
(48 h analysis; Dunnett’s post-test).
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FIGURE 4 | Nitric oxide from microglia origin decreases the activation
of the ERK1/2 signaling pathway. Decreased phosphorylation of ERK1/2
in iNOS+/+ mixed culture, but not in iNOS−/− mixed culture lysates,
following exposure to LPS plus IFN-γ. One-way ANOVA (Bonferroni’s
post-test). ***p < 0.001, significantly different from control.
all the conditions tested in this study (Boje and Arora, 1992;
Dawson et al., 1993, 1994; Bal-Price and Brown, 2001). In addi-
tion, we assessed the activation of the ERK/MAPK signaling
pathway, which is involved in the regulation of SVZ-derived NSC
proliferation downstream of EGFR (Reynolds and Weiss, 1996;
Doetsch et al., 2002; Carreira et al., 2010, 2012). High levels of NO,
achieved following treatment with NOC-18, decreased the phos-
phorylation of ERK1/2 in SVZ-derived NSC cultures, suggesting
an inhibition of the signaling pathway controlling NSC prolif-
eration after exposure to NO. MnTBAP prevented the decrease
in the phosphorylation of ERK1/2 and was also able to rescue
cell proliferation to control levels, suggesting that the antiprolif-
erative effect of NO is mostly due to the formation of nitrogen
reactive species, which compromises signaling through the MAPK
pathway.
Furthermore, we show that LPS plus IFN-γ decreased the
activation of the ERK pathway downstream of the EGFR in
iNOS+/+ mixed cultures, which was prevented by MnTBAP
and FeTMPyP. This event was not observed in iNOS−/− mixed
cultures, where no differences were found in the phosphoryla-
tion status of ERK following treatment with LPS plus IFN-γ.
Here we hypothesized that the antiproliferative effect of inflam-
mation is mediated by NO production, causing a decreased
signaling through the ERK/MAPK pathway. This event might be
mediated by intermediate formation of nitrogen reactive species,
such as ONOO−, since high levels of NO can inhibit mitochon-
drial respiration and elicit superoxide production (Beltran et al.,
2002; Moncada and Bolanos, 2006; Calabrese et al., 2009). Dif-
ferent mechanisms by which microglia impairs neurogenesis in
inflammatory conditions have been reported, which involves the
release of proinflammatory mediators, such as IL-1 (Ben-Hur
et al., 2003), IL-6 (Ekdahl et al., 2003), IFN-γ (Butovsky et al.,
2006), and TNF-alpha (Iosif et al., 2006; for review on this topic;
see Sierra et al., 2014). In addition, in several pathophysiologi-
cal conditions associated with inflammatory processes, activated
inflammatory cells generate large amounts of reactive oxygen
species such as superoxide, hydrogen peroxide and the hydroxyl
FIGURE 5 | Mn(III)tetrakis(4-benzoic acid)porphyrin chloride or
FeTMPyP prevents the antiproliferative effect of NO. (A) Decreased
phosphorylation of ERK1/2 in iNOS+/+ mixed cultures, following exposure
to LPS plus IFN-γ. Either MnTBAP or FeTMPyP partially prevented the
decrease of ERK1/2 phosphorylation. One-way ANOVA (Bonferroni’s
post-test). *p < 0.05 or ***p < 0.001, significantly different from control.
###p < 0.001 or #p < 0.05, significantly different from LPS plus IFN-γ. (B)
Representative images of the incorporation of EdU in SVZ cells cultured
together with iNOS+/+ microglia, following 24 h exposure to LPS plus
IFN-γ with or without MnTBAP (100 μM) or FeTMPyP (50 μM). (i) Control;
(ii) LPS plus IFN-γ; (iii) LPS plus IFN-γ plus MnTBAP; (iv) LPS plus IFN-γ plus
FeTMPyP. Scale bar: 20 μm. (C) Incorporation of EdU in iNOS+/+ mixed
cultures upon treatment with LPS plus IFN-γ for 24 h, with or without
MnTBAP (100 μM) or FeTMPyP (50 μM). One-way ANOVA (Bonferroni’s
post-test); ***p < 0.001, significantly different from control; #p < 0.05 or
##p < 0.01, significantly different from LPS plus IFN-γ.
radical, concomitantly with increased iNOS expression and pro-
duction of large amounts of NO. NO and superoxide readily react
to form ONOO−, which is an extremely reactive molecule (Beck-
man and Crow, 1993; Ischiropoulos and al-Mehdi, 1995; Pryor
and Squadrito, 1995; Radi et al., 2001), also making it very dif-
ficult to experimentally measure the production of superoxide
in conditions where NO is present. Nitration is an irreversible
chemical modification occurring in proteins that results from
the reaction of ONOO− with amino acid residues, particularly
tyrosine (Hanafy et al., 2001). Tyrosine nitration seriously affects
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FIGURE 6 | High levels of NO decrease the activation of the ERK1/2
signaling pathway. (A) High levels of NOC-18 (100 μM) decreased the
phosphorylation of ERK1/2 in SVZ cell lysates. MnTBAP prevented the
decrease of ERK1/2 phosphorylation. One-way ANOVA (Bonferroni’s
post-test). *p < 0.05, significantly different from control. (B) MnTBAP
(100 μM) prevented the antiproliferative effect of NOC-18 (100 μM) in SVZ
cell cultures, as determined by BrdU incorporation. One-way ANOVA
(Bonferroni’s post-test). *p < 0.05, significantly different from control.
##p < 0.01, significantly different from NOC-18.
tyrosine phosphorylation/dephosphorylation signaling cascades
(Monteiro et al., 2008).
Indeed, in this work we also observed that exposure to a high
concentration of NO caused the nitration of the EGF receptor in
iNOS+/+ mixed cultures. We observed that the increased produc-
tion of NO by iNOS+/+ microglia triggered by treatment with
LPS plus IFN-γ is concomitant with increased nitration of the
EGF receptor, which correlates with a decreased signaling through
the ERK/MAPK pathway, leading to an antiproliferative effect on
SVZ-derived NSCs. Moreover, lack of NO (by knockout of iNOS),
prevented the nitration of the EGF receptor under inflamma-
tory conditions. Indeed, in iNOS−/− mixed cultures, although
there was activation of microglial cells following treatment with
LPS plus IFN-γ, which was characterized by the presence of
morphologic changes, no differences in cell proliferation were
found when compared to untreated cultures. Several studies have
shown that the pharmacological inhibition of inflammation trig-
gered by injection of LPS (Monje et al., 2003), or experimentally
induced seizures (Ekdahl et al., 2003), can restore hippocampal
neurogenesis. However, some pro-inflammatory mediators, such
as interleukin-6 (IL-6), released by activated microglia, seem
to be important contributors to the inhibition of SGZ neuro-
genesis (Vallieres et al., 2002; Monje et al., 2003). On the other
hand, microglia can also release trophic factors (Batchelor et al.,
1999), like brain-derived neurotrophic factor (BDNF), that has
been reported to promote neurogenesis (Benraiss et al., 2001).
Thus, activated microglia may have a beneficial or detrimental role
depending on the stimulus, and local and temporal environmental
changes during a lesion to the nervous system (Kettenmann et al.,
2011).
It should be noted that in mixed cultures cells are in close con-
tact, therefore, it is very likely that in iNOS+/+ mixed cultures,
NO levels achieved locally can be even higher, as evidenced by the
increased nitration of the EGF receptor following acute stimula-
tion of microglial cells with LPS plus IFN-γ. Moreover, we showed
that scavenging nitrogen reactive species formation, by MnTBAP
or FeTMPyP treatment (Misko et al., 1998; Salvemini et al., 1998),
restored basal cell proliferation and nitration of the EGF receptor
was prevented in iNOS+/+ mixed cultures.
Our data further indicates that concomitantly with increased
nitration in tyrosine residues of the EGF receptor, NO decreased
the phosphorylation status of this receptor, possibly by inhibiting
the tyrosine kinase activity of EGFR, which has over 15 tyro-
sine residues that can be phosphorylated and contribute to its
activation. We demonstrate that nitration of tyrosine residues
prevents the phosphorylation of such tyrosine residues in the
EGF receptor, which is paramount for its activation and down-
stream signaling. In addition, MnTBAP or FeTMPyP prevented
the decrease in the phosphorylation status of the EGF receptor
in iNOS+/+ mixed cultures challenged with LPS plus IFN-
γ. Altogether, these evidences support our hypothesis that the
antiproliferative effect of inflammation is mediated by NO pro-
duction. NOfrom inflammatoryorigin is involved in thedecreased
activation of the ERK/MAPK pathway, which is mainly caused by
the nitration of EGFR receptor, which compromises its phospho-
rylation and further signaling. Some studies have reported that
NO can have an antiproliferative effect by affecting the phos-
phorylation of the EGF receptor in fibroblasts (Estrada et al.,
1997), neuroblastoma cells (Murillo-Carretero et al., 2002, 2009),
and NSCs (Torroglosa et al., 2007). In fact, in neuroblastoma
cells, it was shown that NO inhibits the EGF receptor by S-
nitrosylation (Murillo-Carretero et al., 2009), but the inhibitory
effect of NO produced by microglia (via inducible NO syn-
thase) in NSC proliferation was only now addressed in our
study.
To our knowledge, this is the first study showing nitration of the
EGF receptor as the main cause to the impairment of the signaling
through the ERK/MAPK pathway, particularly under inflamma-
tory conditions, which compromise proliferation of NSCs. In
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FIGURE 7 | Nitric oxide from inflammatory origin has an
antiproliferative effect, via nitration and decreased phosphorylation of
the EGF receptor, in iNOS+/+ mixed cultures. (A) Decreased
phosphorylation of tyrosine residues (P-Tyr 1173) in iNOS+/+ mixed
culture, but not in iNOS−/− mixed culture lysates, following exposure to
LPS plus IFN-γ. Both MnTBAP or FeTMPyP partially prevented the
decrease of tyrosine phosphorylation in the EGFR. EGFR or GADPH were
used as loading controls. One-way ANOVA (Bonferroni’s post-test).
*p < 0.05, significantly different from Control. ###p < 0.001 or
##p < 0.01, significantly different from LPS plus IFN-γ. Two-tailed t -test
(iNOS−/− mixed culture); p > 0.05. (B) Nitration of the EGFR in SVZ cells
in mixed cultures with iNOS+/+ microglia, but not with iNOS−/−
microglia, following stimulation with LPS plus IFN-γ for 24 h. MnTBAP
(100 μM) and FeTMPyP (50 μM) prevented the nitration of the EGFR in
iNOS+/+ mixed cultures, following exposure to LPS plus IFN-γ for 24 h.
Nitration was assessed by immunoblotting against the EGFR, after
immunoprecipitation of the nitrated proteins (IP-3NT). EGFR or GAPDH
were used as loading controls. One-way ANOVA (Bonferroni’s post-test).
**p < 0.01, significantly different from Control. ###p < 0.001, significantly
different from LPS plus IFN-γ.
Caco-2 cells (cell line obtained from human colon carcinoma),
nitration of EGFR was first observed following the exposure to
ONOO− (Uc et al., 2003). Several other players of the EGFR
signaling cascade are also likely to be susceptible to nitration,
since they also have tyrosine residues that participate in EGFR
signaling by phosphorylation/dephosphorylation and may, thus,
be nitrated and inactivated. Although we did not address these
other players in this work, it cannot be excluded that other partic-
ipants in proliferation signaling, other than the EGF receptor and
downstream signaling cascades, can be affected by NO-mediated
nitration, particularly in inflammatory conditions. Moreover, the
antiproliferative effect of acute inflammatory conditions may be
related to the enhancement of cell differentiation, where NO is
likely to be a player. There is evidence showing that NO from
inflammatory origin is involved in astrogliogenesis (Covacu et al.,
2006; Bergsland et al., 2014), neurogenesis in the SVZ (Walton
et al., 2006), or oligodendrogenesis (Kempermann and Neumann,
2003; Butovsky et al., 2006).
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In previous works by our group we reported that low lev-
els of NO, although in the pathophysiological range, have a
proliferative effect in SVZ-derived NSCs by targeting two path-
ways in a biphasic manner, initially mediated by the ERK/MAP
kinase pathway (Carreira et al., 2010) and at later stages by the
cGMP/PKG pathway (Carreira et al., 2012). In this work, we
observed that higher levels of NO have an opposite effect by pre-
venting regular proliferation signaling through the ERK/MAPK
pathway through the nitration of the EGF receptor which caused
a decrease in its phosphorylation. Although we did not test
the effect of low dose of NO or contribution of cGMP/PKG
in our mixed culture model, we cannot exclude a possible
effect of high levels of NO in preventing regular signaling
through this pathway, as already described by others in a
pathological context both in vitro and in vivo (Zhang et al.,
2002, 2012; for review on this topic; see Zhang et al., 2013).
One of the mechanisms underlying NO toxicity in neurogenic
niches includes ONOO− formation, an event that has been
described in vivo after ischemic stroke (Keynes and Garthwaite,
2004).
Overall, our findings highlight that control of the nitrergic sys-
tem may be an important target in cell transplantation techniques,
particularly in the case of grafting of NSC in lesioned areas. Pub-
lished evidence demonstrates that surviving grafts are influenced
by the innate immune response, particularly due to acutemicroglia
activation,which significantly impacts the survival and fate of both
endogenous and transplanted neural progenitor cells (Monje et al.,
2002, 2003; Ekdahl et al., 2003; Ormerod et al., 2008). In this con-
text, this work highlights a mechanism that may be involved in the
deleterious effect of inflammation in the viability of grafted NSCs,
which is mediated by high levels of NO produced by microglia via
iNOS.
Nevertheless, we show that it is possible to prevent the
antiproliferative effects of microglia during an acute inflamma-
tory response, by preventing the formation of nitrogen reactive
species, with could be used as a strategy to improve the effi-
ciency of transplantation techniques. Overall, our work sheds new
light into the mechanisms underlying the effects of NO on the
proliferation of NSCs, and may help in steering research efforts
toward understanding how modulation of the nitrergic system
can be used to regulate proliferation of stem cells in a regenerative
context.
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